Pinealon

Separate research cited in the video indicates that Pinealon protects the pineal gland cells responsible for melatonin production, as well as brain cells more broadly, from cumulative damage caused by stress and aging. The proposed mechanism is preventive rather than restorative — protecting the cellular machinery before breakdown occurs rather than attempting to revive an already-degraded gland. No specific dosages or study citations beyond this description were provided.

A 2014 study by the research group behind Pinealon found that the peptide switches on a gene responsible for helping the brain build serotonin. Since serotonin is the direct precursor to melatonin, this represents a proposed upstream mechanism by which Pinealon may support the body's natural sleep hormone production pathway. This is not described as a generic effect but as a targeted influence on the melatonin biosynthesis production line. No dosage information was provided in the transcript.

The speaker distinguishes Pinealon from generic neuroprotective agents by emphasizing that its sleep-related effects are mechanistically specific — operating through the serotonin-to-melatonin production pathway rather than incidentally touching sleep as a side effect of broad brain protection. This framing positions Pinealon as a purpose-built support tool for the melatonin biosynthesis system. No dosage, frequency, or stacking information was discussed.

Pinealon is described as a synthetic tripeptide (three amino acids) developed by the same research group responsible for Epithalon (referred to as 'patalon' in the transcript). Unlike general neuroprotective peptides, it was specifically engineered to target brain cells and the cellular population within the pineal gland. No dosage or administration protocol was mentioned in the transcript.